Scientists Turn One Stem Cell Into 14 Million Cancer-Fighting NK Cells
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
20 articles
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
Ossium Health is banking donor bone marrow for on-demand transplant, targeting immune aging as a future healthspan intervention.
New research reveals how tumors reprogram neutrophils to produce CCL3, turning immune defenders into cancer allies.
Rockefeller scientists reprogrammed blood stem cells to produce rare broadly neutralizing antibodies, offering a potential one-time immunity platform.
Australian biotech company creates targeted treatment that attacks malignant plasma cells while sparing healthy ones in multiple myeloma patients.
Scarlet Therapeutics grows universal red blood cells that survive as long as donated ones, opening a path to engineered therapeutic blood.
A Cleveland Clinic hematologist explains how exploding CAR-T options and new drug classes are reshaping myeloma care and patient decisions.
Boston Children's Hospital researchers found blood cancer mutations in brain immune cells, opening new Alzheimer's treatment and screening paths.
Five beta thalassemia patients no longer need regular blood transfusions after Chinese gene therapy treatment.
When tumors hide from killer T cells, they accidentally expose themselves to helper T cells that trigger a lethal iron-driven cell death process.
McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.
The FDA fast-tracked sonrotoclax for relapsed mantle cell lymphoma, with 52% of patients responding in trials โ a new option when others fail.
New 'off-the-shelf' CAR-T therapy eliminated detectable lymphoma cells in over half of treated patients in early clinical data.
A protein called HOXD13 drives skin cancer growth and shields tumors from immune cells โ disabling it could unlock powerful new treatments.
New research reveals how mutant lung cells reprogram surrounding tissue into a tumor-friendly niche โ before cancer is even detectable.
Researchers identify N4BP2, the enzyme behind chromothripsis - a genetic catastrophe that helps one in four cancers rapidly evolve and resist treatment.
A small but striking trial shows CAR-T immunotherapy eliminated all detectable myeloma cells in high-risk pre-cancer patients, prompting talk of cure.
QT-019B targets two cancer markers at once using off-the-shelf engineered T cells, now holding every major FDA expedited development status.
Scientists discover brain support cells help glioblastoma grow and identify existing HIV drug that could disrupt this deadly communication.
A new perspective outlines how stem cells, bioprinted organs, and cross-species genes could replace โ not just repair โ aging biology.